These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 23194144)

  • 1. What is the best approach to tailoring hydrocortisone dose to meet patient needs in 2012?
    Debono M; Ross RJ
    Clin Endocrinol (Oxf); 2013 May; 78(5):659-64. PubMed ID: 23194144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel strategies for hydrocortisone replacement.
    Debono M; Price JN; Ross RJ
    Best Pract Res Clin Endocrinol Metab; 2009 Apr; 23(2):221-32. PubMed ID: 19500765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doses and steroids to be used in primary and central hypoadrenalism.
    Debono M; Ross RJ
    Ann Endocrinol (Paris); 2007 Sep; 68(4):265-7. PubMed ID: 17651687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency.
    Mah PM; Jenkins RC; Rostami-Hodjegan A; Newell-Price J; Doane A; Ibbotson V; Tucker GT; Ross RJ
    Clin Endocrinol (Oxf); 2004 Sep; 61(3):367-75. PubMed ID: 15355454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia.
    Merza Z; Rostami-Hodjegan A; Memmott A; Doane A; Ibbotson V; Newell-Price J; Tucker GT; Ross RJ
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):45-50. PubMed ID: 16817818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation.
    Johannsson G; Nilsson AG; Bergthorsdottir R; Burman P; Dahlqvist P; Ekman B; Engström BE; Olsson T; Ragnarsson O; Ryberg M; Wahlberg J; Biller BM; Monson JP; Stewart PM; Lennernäs H; Skrtic S
    J Clin Endocrinol Metab; 2012 Feb; 97(2):473-81. PubMed ID: 22112807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified-release hydrocortisone for circadian therapy: a proof-of-principle study in dexamethasone-suppressed normal volunteers.
    Newell-Price J; Whiteman M; Rostami-Hodjegan A; Darzy K; Shalet S; Tucker GT; Ross RJ
    Clin Endocrinol (Oxf); 2008 Jan; 68(1):130-5. PubMed ID: 17803699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replacement therapy of oral hydrocortisone in adrenal insufficiency: the influence of gastrointestinal factors.
    Lennernäs H; Skrtic S; Johannsson G
    Expert Opin Drug Metab Toxicol; 2008 Jun; 4(6):749-58. PubMed ID: 18611115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving outcomes in patients with adrenal insufficiency: a review of current and future treatments.
    Johannsson G; Skrtic S; Lennernäs H; Quinkler M; Stewart PM
    Curr Med Res Opin; 2014 Sep; 30(9):1833-47. PubMed ID: 24849526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy.
    Debono M; Ross RJ; Newell-Price J
    Eur J Endocrinol; 2009 May; 160(5):719-29. PubMed ID: 19168600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of short-term nocturnal cortisol replacement on cognitive function and quality of life in patients with primary or secondary adrenal insufficiency: a pilot study.
    Harbeck B; Kropp P; Mönig H
    Appl Psychophysiol Biofeedback; 2009 Jun; 34(2):113-9. PubMed ID: 19387826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal glucocorticoid therapy.
    Debono M; Ross RJ
    Endocr Dev; 2011; 20():173-180. PubMed ID: 21164270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replication of cortisol circadian rhythm: new advances in hydrocortisone replacement therapy.
    Chan S; Debono M
    Ther Adv Endocrinol Metab; 2010 Jun; 1(3):129-38. PubMed ID: 23148157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic evidence for suboptimal treatment of adrenal insufficiency with currently available hydrocortisone tablets.
    Simon N; Castinetti F; Ouliac F; Lesavre N; Brue T; Oliver C
    Clin Pharmacokinet; 2010 Jul; 49(7):455-63. PubMed ID: 20528006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, crossover study comparing two- and four-dose hydrocortisone regimen with regard to quality of life, cortisol and ACTH profiles in patients with primary adrenal insufficiency.
    Ekman B; Bachrach-Lindström M; Lindström T; Wahlberg J; Blomgren J; Arnqvist HJ
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):18-25. PubMed ID: 22288685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Modified-release hydrocortisone for glucocorticoid deficiency].
    Nowotny H; Reisch N
    Internist (Berl); 2020 Jun; 61(6):565-572. PubMed ID: 32394073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortisol Circadian Rhythm and Insulin Resistance in Muscle: Effect of Dosing and Timing of Hydrocortisone Exposure on Insulin Sensitivity in Synchronized Muscle Cells.
    Negri M; Pivonello C; Simeoli C; Di Gennaro G; Venneri MA; Sciarra F; Ferrigno R; de Angelis C; Sbardella E; De Martino MC; Colao A; Isidori AM; Pivonello R
    Neuroendocrinology; 2021; 111(10):1005-1028. PubMed ID: 33130679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian hormone profiles and insulin sensitivity in patients with Addison's disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy.
    Björnsdottir S; Øksnes M; Isaksson M; Methlie P; Nilsen RM; Hustad S; Kämpe O; Hulting AL; Husebye ES; Løvås K; Nyström T; Bensing S
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):28-35. PubMed ID: 25400085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is physiological glucocorticoid replacement important in children?
    Porter J; Blair J; Ross RJ
    Arch Dis Child; 2017 Feb; 102(2):199-205. PubMed ID: 27582458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An oral multiparticulate, modified-release, hydrocortisone replacement therapy that provides physiological cortisol exposure.
    Whitaker M; Debono M; Huatan H; Merke D; Arlt W; Ross RJ
    Clin Endocrinol (Oxf); 2014 Apr; 80(4):554-561. PubMed ID: 23980724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.